Dr.Wang Yuandong

Formerly served as President of Guangzhou Medical University Cancer Hospital; Head of Oncology Surgery at Southern Medical University Cancer Center; President of Guangzhou Anti-Cancer Association; Recipient of the "Outstanding Contributor" award from the Chinese Anti-Cancer Association on its 40th anniversary; Standing Director of the Chinese Society of Clinical Oncology (CSCO); Member of the American Society of Clinical Oncology; Member of the European Society for Medical Oncology; Director of the Chinese Anti-Cancer Association; Vice Chairman of the 3rd and 4th Sessions of the Chinese Society of Oncology; Standing Committee Member of the 1st Session of the Guangdong Provincial Medical Association Oncology Physicians Branch; Deputy Leader of the Guangdong Provincial Cancer Prevention and Control Expert Group; Consultant to the Lung Cancer Committee of the Guangdong Provincial Anti-Cancer Association; Member of the Guangzhou Municipal Cadre Medical Care Expert Group, etc.

Studied under Professor Shao Lingfang, a pioneer in esophageal surgery in my country, and has dedicated over 30 years to the field of thoracic oncology surgery. In the treatment of esophageal and gastric cardia cancer, he has innovatively developed the "narrow-edge dense suture double-angle suspension" anastomosis technique for over 20 years, achieving remarkable therapeutic results. Furthermore, he is actively involved in cutting-edge research areas such as comprehensive treatment of large thoracic tumors, comprehensive treatment of lung cancer, and tumor immune cells, achieving fruitful results in these areas and opening up new ideas and methods for the treatment of related diseases. He serves on the editorial boards of authoritative oncology journals such as Chinese Journal of Oncology, Clinical Oncology, Journal of Oncology, and Esophageal Surgery, and has published numerous academic papers in well-known domestic and international journals.

Medical Expertise: Proficient in the surgical treatment and comprehensive treatment of thoracic tumors such as esophageal cancer, lung cancer, breast cancer, and mediastinal tumors. He combines surgery with radiotherapy, chemotherapy, targeted therapy, and immunotherapy to develop personalized treatment plans for patients. Meanwhile, they possess rich practical experience and profound professional expertise in radiofrequency ablation of lung metastases and hyperthermic perfusion therapy for malignant pleural effusions, enabling them to accurately grasp the timing and methods of treatment and formulate scientific and effective treatment strategies for patients.